{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:15:20Z","timestamp":1783350920798,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302574, 81771758"],"award-info":[{"award-number":["81302574, 81771758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","award":["JX10231802"],"award-info":[{"award-number":["JX10231802"]}],"id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2017YFC0907601, 2017YFC0907605"],"award-info":[{"award-number":["2017YFC0907601, 2017YFC0907605"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Primary Sj\u00f6gren\u2019s syndrome (pSS) is a chronic systemic autoimmune disease which has focal lymphocytic infiltration including a majority of CD4+ T cells. This study was to investigate the correlation of peripheral granzyme B (GranzB)-expressing CD4+ T cells with disease severity and histological lesion in patients with pSS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We recruited 116 pSS and 46 health control (HC) using flow cytometry to examine the percentage of CD4+GranzB+CTLs in the peripheral blood, and immunofluorescence to test their expression in the labial gland.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The percentage of CD4+GranzB+CTLs was significantly upregulated in pSS than in HC (7.1 \u00b1 4.9% vs 3.1 \u00b1 1.9%, <jats:italic>p<\/jats:italic> &lt; 0.0001) and positive correlation with ESSDAI. The frequency of them was markedly higher in pSS with extraglandular manifestations. After excluding the other risk factors associated with pSS, they were still related to ESSDIA and extraglandular manifestations independently (<jats:italic>p<\/jats:italic> &lt; 0.05), and they are the risk factor of extraglandular involvement (odds ratio = 1.928). Moreover, they could be observed in the LSGs. ROC curve analysis indicated that the area under the curve (AUC) of CD4+GranzB+CTLs was 0.796 to predict the activity of pSS and 0.851 to presume extraglandular manifestations. The best diagnostic cutoff point was 4.865 for pSS patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this study, we provide new evidence indicating the involvement of CD4+GranzB+CTLs over activation in the pathophysiology of pSS, which may serve as a new biomarker to evaluate the activity and severity of pSS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13075-021-02632-6","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T22:08:29Z","timestamp":1634076509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Correlation of peripheral CD4+GranzB+CTLs with disease severity in patients with primary Sj\u00f6gren\u2019s syndrome"],"prefix":"10.1186","volume":"23","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanlan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3254-9167","authenticated-orcid":false,"given":"Lei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"key":"2632_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/acr.21610","volume":"64","author":"AS Malladi","year":"2012","unstructured":"Malladi AS, Sack KE, Shiboski SC, Shiboski CH, Baer AN, Banushree R, et al. Primary Sjogren\u2019s syndrome as a systemic disease: a study of participants enrolled in an international Sjogren\u2019s syndrome registry. Arthritis Care Res (Hoboken). 2012;64:911\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2632_CR2","doi-asserted-by":"crossref","unstructured":"P.Brito-Zer\u00b4on and M.Ramos-Casals. Advances in the understanding and treatment of systemic complications in Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol 2014;26:520-527.","DOI":"10.1097\/BOR.0000000000000096"},{"key":"2632_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1573397112666160714164149","volume":"13","author":"S Pulukool","year":"2017","unstructured":"Pulukool S, Biji TK, Debashish D, Robert HS. Update on pathogenesis of Sj\u00f6gren\u2019s syndrome. Curr Rheumatol Rev. 2017;13:5\u201322.","journal-title":"Curr Rheumatol Rev"},{"key":"2632_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/sji.12079","volume":"78","author":"A Karabiyik","year":"2013","unstructured":"Karabiyik A, Peck AB, Nguyen CQ. The important role of T cells and receptor expression in Sj\u00f6gren\u2019s syndrome. Scand J Immunol. 2013;78:157\u201366.","journal-title":"Scand J Immunol"},{"key":"2632_CR5","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1586\/1744666X.2014.900441","volume":"10","author":"D Zhou","year":"2014","unstructured":"Zhou D, McNamara NA. Macrophages: important players in primary Sj\u00f6gren\u2019s syndrome? Expert Rev Clin Immunol. 2014;10:513\u201320.","journal-title":"Expert Rev Clin Immunol"},{"key":"2632_CR6","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1038\/labinvest.3780203","volume":"80","author":"SC van Blokland","year":"2000","unstructured":"van Blokland SC, Wierenga-Wolf AF, van Helden-Meeuwsen CG, Drexhage HA, Hooijkaas H, van de Merwe JP, et al. Professional antigen presenting cells in minor salivary glands in Sj\u00f6gren\u2019s syndrome: potential contribution to the histopathological diagnosis? Lab Invest. 2000;80:1935\u201341.","journal-title":"Lab Invest"},{"key":"2632_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1006\/clin.1994.1123","volume":"72","author":"HM Moutsopoulos","year":"1994","unstructured":"Moutsopoulos HM. Sj\u00f6gren\u2019s syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994;72:162\u20135.","journal-title":"Clin Immunol Immunopathol"},{"key":"2632_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","volume":"34","author":"MI Christodoulou","year":"2010","unstructured":"Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM. Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren\u2019s syndrome. J Autoimmun. 2010;34:400\u20137.","journal-title":"J Autoimmun"},{"key":"2632_CR9","first-page":"194","volume":"23","author":"A Takeuchi","year":"2017","unstructured":"Takeuchi A, Saito T. CD4 CTL, a cytotoxic subset of CD4+ T cells, their differentiation and function. Front Immunol. 2017;23:194.","journal-title":"Front Immunol"},{"key":"2632_CR10","first-page":"93","volume":"9","author":"DM Brown","year":"2016","unstructured":"Brown DM, Lampe AT, Workman AM. The differentiation and protective function of cytolytic CD4 T cells in influenza infection. Front Immunol. 2016;9:93.","journal-title":"Front Immunol"},{"key":"2632_CR11","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1046\/j.1365-2249.1998.00705.x","volume":"114","author":"M Polihronis","year":"1998","unstructured":"Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM. Modes of epithelial cell death in Sj\u00f6gren\u2019s syndrome (SS). Clin Exp Immunol. 1998;114:485\u201390.","journal-title":"Clin Exp Immunol"},{"key":"2632_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1080\/03009740310000067","volume":"32","author":"P Sfriso","year":"2003","unstructured":"Sfriso P, Ostuni P, Botsios C, Andretta M, Oliviero F, Punzi L, et al. Serum and salivary neopterin and interferon-gamma in primary Sj\u00f6gren\u2019s syndrome. Correlation with clinical, laboratory and histopathologic features. Scand J Rheumatol. 2003;32:74\u20138.","journal-title":"Scand J Rheumatol"},{"key":"2632_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1046\/j.1365-2249.1999.01037.x","volume":"118","author":"G Xanthou","year":"1999","unstructured":"Xanthou G, Tapinos NI, Polihronis M, Nezis IP, Margaritis LH, Moutsopoulos HM. CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sj\u00f6gren\u2019s syndrome. Clin Exp Immunol. 1999;118:154\u201363.","journal-title":"Clin Exp Immunol"},{"key":"2632_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","volume":"76","author":"T Maehara","year":"2017","unstructured":"Maehara T, Mattoo H, Ohta M, Mahajan VS, Moriyama M, Yamauchi M, et al. Lesional CD4+ IFN-\u03b3+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis. Ann Rheum Dis. 2017;76:377\u201385.","journal-title":"Ann Rheum Dis"},{"key":"2632_CR15","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554\u20138.","journal-title":"Ann Rheum Dis"},{"key":"2632_CR16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/1744666X.2016.1109449","volume":"12","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, et al. Early diagnosis of primary Sj\u00f6gren\u2019s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol. 2016;12:137\u201356.","journal-title":"Expert Rev Clin Immunol"},{"key":"2632_CR17","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, et al. EULAR Sj\u00f6gren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2010;69:1103\u20139.","journal-title":"Ann Rheum Dis"},{"key":"2632_CR18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1136\/jcp.21.5.656","volume":"21","author":"DM Chisholm","year":"1968","unstructured":"Chisholm DM, Mason DK. Labial salivary gland biopsy in Sj\u00f6gren\u2019s disease. J Clin Pathol. 1968;21:656\u201360.","journal-title":"J Clin Pathol"},{"key":"2632_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.clim.2017.03.007","volume":"182","author":"AV Goules","year":"2017","unstructured":"Goules AV, Kapsogeorgou EK, Tzioufas AG. Insight into pathogenesis of Sj\u00f6gren\u2019s syndrome: dissection on autoimmune infiltrates and epithelial cells. Clin Immunol. 2017;182:30\u201340.","journal-title":"Clin Immunol"},{"key":"2632_CR20","doi-asserted-by":"publisher","first-page":"24242","DOI":"10.1073\/pnas.1907883116","volume":"116","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K, Kouno T, Ikawa T, Hayatsu N, Miyajima Y, Yabukami H, et al. Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proc Natl Acad Sci U S A. 2019;116:24242\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2632_CR21","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/art.38726","volume":"66","author":"C Croia","year":"2014","unstructured":"Croia C, Astorri E, Murray-Brown W, Willis A, Brokstad KA, Sutcliffe N, et al. Implication of Epstein-Barr virus infection in disease-specific autoreactive B cell activation in ectopic lymphoid structures of Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2014;66:2545\u201357.","journal-title":"Arthritis Rheumatol"},{"key":"2632_CR22","doi-asserted-by":"crossref","unstructured":"Schmidt D, Goronzy JJ, Weyand CM. CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 1996;97:2027\u20132037.","DOI":"10.1172\/JCI118638"},{"key":"2632_CR23","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.2174\/138161211798764834","volume":"17","author":"IE Dumitriu","year":"2011","unstructured":"Dumitriu IE, Kaski JC. The role of T and B cells in atherosclerosis: potential clinical implications. Curr Pharm Des. 2011;17:4159\u201371.","journal-title":"Curr Pharm Des"},{"key":"2632_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s10875-008-9213-4","volume":"28","author":"Z Sun","year":"2008","unstructured":"Sun Z, Zhong W, Lu X, Shi B, Zhu Y, Chen L, et al. Association of Graves\u2019 disease and prevalence of circulating IFN-gamma-producing CD28(-) T cells. J Clin Immunol. 2008;28:464\u201372.","journal-title":"J Clin Immunol"},{"key":"2632_CR25","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1002\/art.27665","volume":"62","author":"JM Pandya","year":"2010","unstructured":"Pandya JM, Fasth AE, Zong M, Arnardottir S, Dani L, Lindroos E, et al. Expanded T cell receptor V\u03b2-restricted T cells from patients with sporadic inclusion body myositis are proinflammatory and cytotoxic CD28null T cells. Arthritis Rheum. 2010;62:3457\u201366.","journal-title":"Arthritis Rheum"},{"key":"2632_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1046\/j.1365-2249.1998.00695.x","volume":"114","author":"F Moosig","year":"1998","unstructured":"Moosig F, Csernok E, Wang G, Gross WL. Costimulatory molecules in Wegener\u2019s granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin Exp Immunol. 1998;114:113\u20138.","journal-title":"Clin Exp Immunol"},{"key":"2632_CR27","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.3389\/fimmu.2017.01160","volume":"20","author":"LM Peeters","year":"2017","unstructured":"Peeters LM, Vanheusden M, Somers V, Van Wijmeersch B, Stinissen P, Broux B, et al. Cytotoxic CD4+ T cells drive multiple sclerosis progression. Front Immunol. 2017;20:1160.","journal-title":"Front Immunol"},{"key":"2632_CR28","first-page":"2609","volume":"43","author":"ME Stern","year":"2002","unstructured":"Stern ME, Gao J, Schwalb TA, Ngo M, Tieu DD, Chan CC, et al. Conjunctival T-cell subpopulations in Sj\u00f6gren\u2019s and non-Sj\u00f6gren\u2019s patients with dry eye. Invest Ophthalmol Vis Sci. 2002;43:2609\u201314.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2632_CR29","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1167\/iovs.07-0069","volume":"48","author":"CS De Paiva","year":"2007","unstructured":"De Paiva CS, Villarreal AL, Corrales RM, Rahman HT, Chang VY, Farley WJ, et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci. 2007;48:2553\u201360.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2632_CR30","doi-asserted-by":"publisher","first-page":"7545","DOI":"10.1167\/iovs.15-17627","volume":"56","author":"SC Pflugfelder","year":"2015","unstructured":"Pflugfelder SC, De Paiva CS, Moore QL, Volpe EA, Li DQ, Gumus K, et al. Aqueous tear deficiency increases conjunctival interferon-gamma (IFNgamma) expression and goblet cell loss. Invest Ophthalmol Vis Sci. 2015;56:7545\u201350.","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02632-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-021-02632-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-021-02632-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T22:30:20Z","timestamp":1634077820000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-021-02632-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2632"],"URL":"https:\/\/doi.org\/10.1186\/s13075-021-02632-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"30 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of Jiangsu Province Hospital (approval number 2017-SR-121), and written informed consent was obtained from each individual.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"257"}}